Urologic-nephrological Care of Chronic Kidney Disease in Saxony-Anhalt/Magdeburg.
NCT ID: NCT02229435
Last Updated: 2014-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1031336 participants
OBSERVATIONAL
2004-12-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients with Chronic kidney disease (CKD) with an estimated glomerular filtration rate (eGFR) under 60 ml/min using the MDRD-6 (Modification of Diet in Renal Disease) formula and/or CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula should undergo nephrological and urological care (diagnosis and treatment) to prevent chronic kidney failure. This is recommended by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI), Kidney Disease Improving Global Outcomes (KDIGO) and European Urological Association (EAU). Renal and postrenal diseases can cause or worsen CKD. Internistic and intrarenal diseases can caused or worsen CKD. All diseases affecting CKD should be treated and the medical care should be optimized.
Hypothesis:
Not all patients with CKD receive urological and nephrological care. Interdisciplinary work of outpatient working urologists and nephrologists in the metropolitan area Magdeburg / Saxony-Anhalt Germany is unknown. An descriptive analysis of interdisciplinary treatment connection of CKD patients for an orientating statement is needed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The CPH-MBD Cohort
NCT07193056
Functional Capacity in Children with Chronic Kidney Disease
NCT06683339
Multiparametric MRI in Healthy Volunteers and CKD Patients
NCT05229263
Prevention of Acute Kidney Injury - Molecular Mechanisms of Dietary Pre-conditioning in Human
NCT02745444
Development of Early Diagnostic Techniques and Setup of Local Therapeutic Guidelines and Standards
NCT00912704
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
eGFR <60ml/min
Patients with CKD with eGFR \<60 ml/min (CKD-EPI or MDRD) 12/2004-08/2014 of Medical Laboratory, Prof. Schenk / Dr. Ansorge and Colleagues, GbR, Am Neustädter Feld 47, 39124 Magdeburg, Germany.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* eGFR \< 60 ml/min
Exclusion Criteria
* no serum creatinine measured
* Age \< 18 years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Laboratory Schenk-Ansorge Magdeburg Germany.
UNKNOWN
University of Magdeburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johann J. Wendler, MD
Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johann J Wendler, Dr.
Role: PRINCIPAL_INVESTIGATOR
Urology University Magdeburg
Martin Schostak, Prof. Dr.
Role: STUDY_CHAIR
Urology University Magdeburg
Herwart Schenk, Prof. Dr.
Role: STUDY_DIRECTOR
Medical Laboratory Am Neustädter Feld 47, 39124 Magdeburg, Saxony-Anhalt, Germany.
Constanze Tienken, Cand. med.
Role: PRINCIPAL_INVESTIGATOR
Doctorand Urology University Magdeburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Urology University Magdeburg
Magdeburg, Saxony-Anhalt, Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Medical Laboratory Schenk-Ansorge Magdeburg, Germany.
Department of Urology University Magdeburg, Germany.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
URO-MD-040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.